Abstract | BACKGROUND: Epidemiological evidence has demonstrated a clear association between diabetes mellitus and increased risk of Alzheimer's disease (AD). Cerebral accumulation of phosphorylated tau aggregates, a cardinal neuropathological feature of AD, is associated with neurodegeneration and cognitive decline. Clinical and experimental studies indicate that diabetes mellitus affects the development of tau pathology; however, the underlying molecular mechanisms remain unknown. OBJECTIVE: In the present study, we used a unique diabetic AD mouse model to investigate the changes in tau phosphorylation patterns occurring in the diabetic brain. DESIGN: RESULTS: Comprehensive phosphoproteomic analysis revealed a unique tau phosphorylation signature in the brains of mice with diabetic AD. Bioinformatic analysis of the phosphoproteomics data revealed putative tau-related kinases and cell signaling pathways involved in the interaction between diabetes mellitus and AD. CONCLUSION: These findings offer potential novel targets that can be used to develop tau-based therapies and biomarkers for use in AD.
|
Authors | Y Ito, S Takeda, T Nakajima, A Oyama, H Takeshita, K Miki, Y Takami, Y Takeya, M Shimamura, H Rakugi, R Morishita |
Journal | The journal of prevention of Alzheimer's disease
(J Prev Alzheimers Dis)
Vol. 11
Issue 1
Pg. 138-148
( 2024)
ISSN: 2426-0266 [Electronic] Switzerland |
PMID | 38230726
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Mice
- Humans
- Animals
- Alzheimer Disease
(metabolism)
- tau Proteins
(metabolism)
- Phosphorylation
- Diet, High-Fat
(adverse effects)
- Disease Models, Animal
- Mice, Transgenic
- Diabetes Mellitus, Type 2
- Cognitive Dysfunction
(complications)
|